slimvictor
Bluelight Crew
Massachusetts Public Health Commissioner John Auerbach resigned Monday in the wake of a growing investigation into a chemist whose alleged mishandling of drug samples led police to shut down the state crime lab and re-examine tens of thousands of drug cases.
Auerbach said it's clear that there was "insufficient quality monitoring, reporting and investigating on the part of supervisors and managers" at the lab, which had been overseen by the Department of Public Health before being transferred to state police as part of a budgetary realignment.
"What happened at the drug lab was unacceptable and the impact on people across the state may be devastating, particularly for some within the criminal justice system." Auerbach said in a written statement Monday. "We owe it to ourselves and the public to make sure we understand exactly how and why this happened."
Auerbach said he will continue to work with investigators.
Gov. Deval Patrick accepted the resignation, calling the failures at the lab serious. He said the actions and inactions of lab management compounded the problem.
Authorities have not released specific details about what chemist Annie Dookhan allegedly did.
But in a letter sent last week to defense attorneys around the state, Max Stern, the president of the Massachusetts Association of Criminal Defense Lawyers said he was told in a meeting with Patrick and other administration officials that the chemist is accused of deliberately tampering with some drug samples, including the weight of the samples, which can affect the length of prison sentences given to people convicted of drug offenses.
"Apparently, the lab analyst in question had unsupervised access to the drug safe and evidence room, and tampered with evidence bags, altered the actual weight of the drugs, did not calibrate machines correctly, and altered samples so that they would test as drugs when they were not," Stern said in the letter.
"The lab is apparently unable to tie this conduct to specific cases. And the conduct appears to have occurred over a prolonged period. There are also questions about supervision of the lab generally, failure to follow and update protocols throughout the lab, the quality of the analyst's work due to the exceptional number of analyses she conducted, and the particular analyst's sign-off on the work of others. "
Read more here:
http://www.sacbee.com/2012/09/17/4828814/mass-health-commissioner-resigns.html#storylink=cpy
Auerbach said it's clear that there was "insufficient quality monitoring, reporting and investigating on the part of supervisors and managers" at the lab, which had been overseen by the Department of Public Health before being transferred to state police as part of a budgetary realignment.
"What happened at the drug lab was unacceptable and the impact on people across the state may be devastating, particularly for some within the criminal justice system." Auerbach said in a written statement Monday. "We owe it to ourselves and the public to make sure we understand exactly how and why this happened."
Auerbach said he will continue to work with investigators.
Gov. Deval Patrick accepted the resignation, calling the failures at the lab serious. He said the actions and inactions of lab management compounded the problem.
Authorities have not released specific details about what chemist Annie Dookhan allegedly did.
But in a letter sent last week to defense attorneys around the state, Max Stern, the president of the Massachusetts Association of Criminal Defense Lawyers said he was told in a meeting with Patrick and other administration officials that the chemist is accused of deliberately tampering with some drug samples, including the weight of the samples, which can affect the length of prison sentences given to people convicted of drug offenses.
"Apparently, the lab analyst in question had unsupervised access to the drug safe and evidence room, and tampered with evidence bags, altered the actual weight of the drugs, did not calibrate machines correctly, and altered samples so that they would test as drugs when they were not," Stern said in the letter.
"The lab is apparently unable to tie this conduct to specific cases. And the conduct appears to have occurred over a prolonged period. There are also questions about supervision of the lab generally, failure to follow and update protocols throughout the lab, the quality of the analyst's work due to the exceptional number of analyses she conducted, and the particular analyst's sign-off on the work of others. "
Read more here:
http://www.sacbee.com/2012/09/17/4828814/mass-health-commissioner-resigns.html#storylink=cpy